Computer simulation of cells may speed up development of protein-degrading drugs

Weill Cornell Medicine investigators have created a computational model that simulates cellular processes to aid in designing protein-degrader therapies, a promising approach for cancer treatment. The model is expected to streamline the development of these drugs by predicting their effects more efficiently. The research was published in Nature Communications on July 13.